NCT04056312

Brief Summary

The current RCT is designed to:

  1. 1.test the efficacy of the group based mSMT in persons with TBI on NPE, the current gold-standard for measuring memory functioning
  2. 2.assess the effectiveness of the group mSMT on more global measures of everyday life, including an objective measure shown through our previous work to be sensitive to memory changes following the mSMT, as well as additional questionnaires to be completed by both the participant and a significant other
  3. 3.evaluate the changes in brain functioning following treatment with the mSMT via fMRI and
  4. 4.evaluate the long-term effects of the treatment protocol.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 29, 2016

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

August 15, 2017

Completed
2 years until next milestone

First Posted

Study publicly available on registry

August 14, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

January 18, 2023

Status Verified

January 1, 2023

Enrollment Period

6 years

First QC Date

August 15, 2017

Last Update Submit

January 16, 2023

Conditions

Keywords

memorylearningcognitiontraumatic brain injurytreatment and therapy

Outcome Measures

Primary Outcomes (2)

  • California Verbal Learning Test

    Change on scores on memory tests will be assessed using the California Verbal Learning Test

    Change will be assessed. Scales will be administered at 3 time points;pretreatment immediately following 5 months later

  • The Traumatic Brain Injury-Quality of Life Scale

    Self-reports of emotional functioning, memory functioning and quality of life on The Traumatic Brain Injury-Quality of Life Scale, which measures these constructs. DVs will be change on the Depression subscale (range: 0-40; lower score is better) and Cognition scale (range: 0-40; higher score is better).

    Change will be assessed. Scales will be administered at 3 time points;pretreatment immediately following 5 months later

Study Arms (2)

Group memory retraining

EXPERIMENTAL

Experimental group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.

Behavioral: Group Memory retraining exercises

Placebo

PLACEBO COMPARATOR

Experimental group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.

Behavioral: Placebo controlled group memory exercise training

Interventions

Experimental group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.

Group memory retraining

Placebo group will be receiving memory retraining exercises via lap top twice a week for 5 weeks. Four people in a group.

Placebo

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • I am between the ages of 18-65.
  • I have had a Traumatic Brain Injury at least one year ago.
  • I can read and speak English fluently.
  • I have difficulties with learning and memory skills.

You may not qualify if:

  • I am currently taking steroids and /or benzodiazepines as determined by study staff review of my medications.
  • I have had a prior stroke or neurological injury/disease other than a traumatic brain injury.
  • I have a history of significant psychiatric illness (for example, bipolar disorder or psychosis) or a current diagnosis of Major Depressive Disorder, Schizophrenia, Bipolar Disorder I or II.
  • I have unstable or uncontrolled seizures.
  • I have a significant alcohol or drug abuse history.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kessler Foundation

West Orange, New Jersey, 07052, United States

Location

MeSH Terms

Conditions

Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Brain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and Injuries

Study Officials

  • Richard Green, PhD

    Kessler Foundation

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director NNL & TBI

Study Record Dates

First Submitted

August 15, 2017

First Posted

August 14, 2019

Study Start

June 29, 2016

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

January 18, 2023

Record last verified: 2023-01

Locations